WO2001064262A2 - Method and system for hemodialysis for use in a non-clinical environment - Google Patents
Method and system for hemodialysis for use in a non-clinical environment Download PDFInfo
- Publication number
- WO2001064262A2 WO2001064262A2 PCT/IB2001/000442 IB0100442W WO0164262A2 WO 2001064262 A2 WO2001064262 A2 WO 2001064262A2 IB 0100442 W IB0100442 W IB 0100442W WO 0164262 A2 WO0164262 A2 WO 0164262A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dialysate
- flow resistance
- flow
- blood
- resistance
- Prior art date
Links
- 238000001631 haemodialysis Methods 0.000 title claims abstract description 26
- 230000000322 hemodialysis Effects 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims description 58
- 230000007246 mechanism Effects 0.000 claims abstract description 70
- 239000008280 blood Substances 0.000 claims abstract description 38
- 210000004369 blood Anatomy 0.000 claims abstract description 38
- 230000017531 blood circulation Effects 0.000 claims abstract description 12
- 239000012528 membrane Substances 0.000 claims abstract description 11
- 238000004891 communication Methods 0.000 claims abstract description 5
- 238000000502 dialysis Methods 0.000 claims description 58
- 238000006467 substitution reaction Methods 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 8
- 206010003226 Arteriovenous fistula Diseases 0.000 claims description 7
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 230000008261 resistance mechanism Effects 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 1
- 238000003825 pressing Methods 0.000 claims 1
- 238000011282 treatment Methods 0.000 description 8
- 230000002596 correlated effect Effects 0.000 description 7
- 230000001684 chronic effect Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000012907 medicinal substance Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 230000003534 oscillatory effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007485 conventional hemodialysis Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000009526 daily hemodialysis Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000002157 hypercatabolic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
- A61M1/1605—Physical characteristics of the dialysate fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1621—Constructional aspects thereof
- A61M1/1643—Constructional aspects thereof with weighing of fresh and used dialysis fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3424—Substitution fluid path
- A61M1/3437—Substitution fluid path downstream of the filter, e.g. post-dilution with filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3441—Substitution rate control as a function of the ultrafiltration rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3441—Substitution rate control as a function of the ultrafiltration rate
- A61M1/3451—Substitution rate control as a function of the ultrafiltration rate the difference in weight between both ultra-filtrate and substitution reservoir being used as control signal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3455—Substitution fluids
- A61M1/3465—Substitution fluids using dialysate as substitution fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3379—Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M2205/3393—Masses, volumes, levels of fluids in reservoirs, flow rates by weighing the reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
Definitions
- the present invention relates to a method and system for hemodialysis.
- the present invention relates to a method and system for hemodialysis that is particularly suited for use in a non-clinical environment.
- hemodialysis sessions traditionally take place three times per week. Each hemodialysis session typically lasts about four hours.
- the present invention is a hemodialysis system that is particularly suited for use in a non-clinical environment.
- the hemodialysis system includes a dialyzer, a pressurizable dialysate supply mechanism, a dialysate collection mechanism, an arterial line, a venous line, a first flow resistance, a second flow resistance, a third flow resistance and a control system.
- the dialyzer has a blood flow path and a dialysate flow path that are in communication through a membrane.
- the blood flow path has a blood entry port and a blood exit port.
- the dialysate flow path has a dialysate entry port and a dialysate exit port.
- the pressurizable dialysate supply mechanism is operably connected to the dialysate entry port.
- the dialysate collection mechanism is operably connected to the dialysate exit port.
- the arterial line is operably connected to the blood entry port.
- the venous line is operably connected to the blood exit port
- the first flow resistance is operably connected between the dialysate supply mechanism and the dialyzer.
- the second flow resistance is operably connected between the dialyzer and the dialysate collection mechanism.
- the third flow resistance is operably connected to the venous line. The control system adjusts pressure in the dialysate supply mechanism, the first flow resistance, the second flow resistance and the third flow resistance to produce desired dialysate and ultrafiltrate flow rates.
- Fig. 1 is a perspective view of a dialysis system of the present invention.
- Fig. 2 is a schematic illustration of the dialysis system.
- Fig. 3 is a sectional view of the dialysis system.
- Fig. 4 is another sectional view of the dialysis system.
- Fig. 5 is an enlarged view of the dialysate supply mechanism illustrated in Fig. 2.
- Fig. 6 is a perspective view of an alternative configuration of the dialysis system.
- Fig. 7 is an enlarged view of the dialysate supply mechanism illustrated in
- Fig. 8 is an alternative embodiment of the dialysis system.
- Fig. 9 is a schematic illustration of the dialysis system.
- Fig. 10 is a graph of a study using the method of the present invention.
- Fig. 11 is a graph of another study using the method of the present invention.
- Fig. 12 is a graph of yet another study using the method of the present invention.
- Fig. 13 is a graph of still another study using the method of the present invention.
- Fig. 14 is a graph comparing the performance of the method of the present invention.
- An embodiment of the present invention relates to a dialysis system and a method of using the dialysis system that is particularly suited for use in a non-clinical environment.
- the dialysis system 10 generally includes a dialyzer 30, a dialysate supply mechanism 32 and a dialysate collection mechanism 34, as most clearly illustrated in Figs. 1 and 2.
- the components of the dialysis system 10 are preferably all contained within an enclosure 36, as most clearly illustrated in Figs. 1, 3 and 4.
- the dialysis system 10 of the present invention through its simplicity of use and controls, allows a patient 18 to perform dialysis treatments in a non-clinical environment such as in the patient's home without the need for skilled medical assistance.
- the present invention is particularly suited for use by patients who are experiencing significant kidney failure such that the patients must be dialyzed regularly, preferably almost daily.
- the dialyzer 30 preferably has a hollow fiber membrane configuration.
- the dialyzer 30 has a blood flow path with a blood entry port 40 and a blood exit port 42, as most clearly illustrated in Figs. 2 and 5.
- the dialyzer 30 also has a dialysate flow path with a dialysate entry port 44 and a dialysate exit port 46.
- the blood flow path and the dialysate flow path are in communication through the hollow fiber membranes.
- the dialysate supply mechanism 32 is operably connected to the dialysate entry port 44 and includes a pressurizable container 50 that is adapted to receive at least one dialysate pouch 52.
- the dialysate container 50 preferably has a housing and a lid that form a strong seal with respect to each other to prevent pressurized gases placed in the dialysate container 50 from escaping therefrom.
- the dialysate container 50 may be pressurized with a gas such as air, nitrogen or any other gas that poses a minimal contamination risk with the dialysate.
- Gas pressure in the dialysate container 50 is preferably controlled by a pressure regulating valve or other suitable device. The pressure control may be accomplished automatically or manually. A person of ordinary skill in the art will appreciate that it is also possible to impart pressure in the dialysate container 50 using mechanical means.
- the dialysate used with the dialysate supply mechanism 32 is preferably sterile, premixed dialysate.
- the dialysate system 10 may be adapted for use with other forms of dialysate such as dialysate concentrate.
- the dialysate is preferably provided in the dialysate supply mechanism 32 in the form of at least one flexible pouch 52 that contains the sterile, premixed dialysate.
- the dialysate supply mechanism 32 may also supply a substitution liquid, which is described in more detail below.
- This embodiment is particularly suited for chronic dialysis where the volume of dialysate needed and the length of the dialysis session are known. Since this volume is relatively reduced of the order of 25 to 40 liters, the container 50 can be configured in such a way that it can contain all the necessary volume for a chronic dialysis treatment.
- the dialysate collection mechanism 34 is operably connected to the dialysate exit port 46 and collects spent dialysate and the ultrafiltrate that is collected from the patient, as most clearly illustrated in Fig 2. Depending on the amount of dialysate used in a dialysate session, the dialysate collection mechanism 34 may collect all of the spent dialysate the ultrafiltrate for later disposal. Alternatively, the dialysate collection mechanism 34 is operably connected to a drain for disposing of the spent dialysate and ultrafiltrate. In certain locations it may also be necessary to use a pump 68 to convey the spent dialysate and ultrafiltrate into the drain.
- the dialysis system 10 of the present invention also includes an arterial line 70 and a venous line 72.
- the arterial line 70 connects the blood entry port 40 to an arteriovenous fistula (not represented in detail) implanted in a forearm of the patient 18.
- the venous line 72 extends between the arteriovenous fistula and a venous chamber 74.
- the venous chamber 74 includes a first entry port 76 and a second entry port 78.
- the first entry port 76 is connected to the blood exit port 42.
- the second entry port 78 is connected to a substitution liquid supply mechanism through line 82.
- the substitution liquid is preferably dialysate that is provided by the dialysate supply mechanism 32.
- a dialysate supply line 84 is connected between a separator 86 that is joined to the dialysate supply mechanism 32.
- the substitution liquid supply line 82 extends between the separator 86 and the venous chamber 74.
- a spent dialysate recovery line 90 is connected to the dialysate exit port 46 to the dialysate collection mechanism 34.
- the dialysis system 10 also preferably includes a pump 92 controls the rate at which the blood is moved through the dialyzer 30.
- the pump 92 is preferably a peristaltic pump. However, a person of ordinary skill in the art will appreciate that alternative pump configurations may also be used.
- the dialysis system 10 also preferably includes a flow meter 88 on the spent dialysate recovery line 90 to measure the rate at which dialysate and ultrafiltrate flows from the dialyzer 30.
- the dialysis system 10 further preferably includes a push syringe 100 or equivalent automatically controlled device for introducing an anticoagulant into the arterial line 70.
- the dialysis system 10 preferably has a control panel 60 with control buttons that permit easy use of the dialysis system 10 by the patient alone or with an assistant who is not necessarily qualified in the operation of dialysis machines, as most clearly illustrated in Fig. 1.
- operation of the dialysis system 10 may be controlled by an infrared remote control.
- the dialysis system 10 may also have provisions for remote operation or monitoring from a distant central facility.
- the lines 84 and 90 that link together the dialysate supply mechanism 32 and/or the substitution liquid to the dialyzer 30 and the venous chamber 74, respectively, in one implementation of the invention may have resistances determined and calibrated in a precise manner.
- the resulting flows are precisely known for a given range of pressure regulated inside the dialysate container 50 and a given range of resistance in the spent dialysate recovery line 90. Each of these items may be adjusted as needed during a dialysis session.
- a first resistance generating device 110 is operably attached to the dialysate supply line 84.
- a second resistance generating device 112 is operably attached to the dialysate recovery line 90.
- a third resistance generating device 114 is operably attached to the venous line 72.
- a fourth resistance generating device 116 is operably attached to the substitution liquid supply line 82.
- the resistance generating devices 110, 112, 114, 116 generate resistance by at least partially restricting the flow through the line to which the resistance generating device is attached.
- the resistance generating devices 110, 112, 114, 114 thereby enable the dialysate feed rate, the ultrafiltrate feed rate, and the substitution liquid feed rate to be adjusted.
- the resistance generating devices 110, 112, 114, 116 are controlled by hand or automatically and are preferably a valve, a narrowing, or an external clamping or any similar device having the requisite functions.
- the resistances generated by the first, second, and fourth resistance generating devices 110, 112, 116 may be predetermined or adjustable according to the use of the machine.
- the resistance generated by the third resistance generating device 114 is variable corresponding to the blood pressure of the patient.
- the resistance produced by the first resistance generating device 110 is preferably predetermined, and the container pressure and the resistance produced by the second resistance generating device 112 is adjustable. It is also possible to predetermine the pressure of the dialysate container 50, and to adjust the resistances produced by the first and second resistance generating devices 110, 112. Preferably, the resistance provided by the first resistance generating device
- the flow of dialysate from the dialysate container 50 is between 80 and 500 milliliters per minute and preferably between 150 and 300 milliliters per minute.
- the dialysis supply mechanism 32 has at least two compartments 92 formed therein, as most clearly illustrated in Figs. 6 and 7. Each of the compartments is adapted to receive at least one of the dialysate pouches 52.
- the compartments 92 are individually pressurizable so that pouches in each compartment 92 may be replaced separately. This embodiment thereby enables the treatment to be done in a continuous and uninterrupted manner.
- the dialysate supply mechanism 32 includes a supplemental dialysate supply device 60, as most clearly illustrated in Figs. 6 and 7.
- the supplemental dialysate supply device 60 preferably includes at least one dialysate pouch 62.
- the dialysate pouches 62 are operably connected to the dialysate pouches 52 in the dialysate container 50 through lines 64 such that at selected times, the dialysate in the dialysate pouches 52 may be replenished from the dialysate pouches 62.
- pouches 52 are left in place in the container, and the refilling occurs by means of pouches 62 that are replaced regularly.
- the presence of two pouches in the container 50 allows an alternate filling by gravity from the reserve pouches. This technique is accomplished through the alternative pinching of lines to fill successively and alternately the pouches 52 in the container 50 from the reserve pouches 62 containing the reserve premixed dialysate.
- the components of the dialysis system 110 are integrated into a chair 102, as most clearly illustrated in Fig. 8.
- the dialyzer 130 and the dialysis supply mechanism 132 are integrated into a back portion 104 of the chair 102.
- the dialysate collection mechanism 134 is integrated in a seat portion 106 of the chair 102.
- the control panel 160 is integrated into an arm portion 108 of the chair 102.
- This embodiment of the present invention enables a person who is undergoing the dialysis session to sit in a comfortable position on the chair 102.
- the control panel 160 folds at least partially into the arm portion 108 so that the chair 102 may be used as a conventional piece of furniture in the patient's home.
- a first weight of dialysate to be used is measured prior to use, and a second weight of the dialysate plus ultrafiltrate is measured continuously during the dialysis session.
- This procedure allows continuous calculation of the ultrafiltrate volume removed from the patient throughout a treatment session by subtraction of the first weight from the second weight or at any time by subtraction of the weight of dialysate used from weight the dialysate plus ultrafiltrate evacuated from the exit of the dialyzer.
- the weight of the dialysate used is the initial weight of the sterile dialysate minus the current weight of the sterile dialysate remaining in the container.
- the hemodialysis method of the present invention permits the determination of the quantity of ultrafiltrate that has been evacuated from a patient during the dialysis by a simple arithmetic calculation.
- the sterile, premixed dialysate "D" under pressure is contained initially, meaning before the dialysis, in a container as described above and one proceeds continuously, during all the length of the dialysis to take a first weight to determine the weight of it or the change in its weight.
- the dialysate along with ultrafiltrate "D + UF” is evacuated continuously during dialysis into a receiving tank and one proceeds continuously, during the length of the dialysis, to take a second weight to determine the weight of the evacuated dialysate plus ultrafiltrate.
- the dialysate supply line 84 can deliver about 25 liters of dialysate to the dialyzer 30, and the substitution liquid supply line 82 can deliver about 5 liters of substitution liquid into the venous line of the patient.
- the hemodiafiltration method permits improvement in the performance of blood purification by allowing an increased fluid convection flow in the dialyzer to take place in addition to diffusion across the membrane of the dialyzer 30.
- the volume of substitution liquid injected into the venous line is withdrawn to the dialysate side of dialyzer during the course of a treatment.
- the machine withdraws through the membrane of the dialyzer 30 a certain quantity of ultrafiltrate fluid from the blood, for example one to two liters per day, that the patient cannot eliminate.
- the resistances produced by the first, second and fourth resistance generating devices 110, 112, 116, and the container pressure are controlled by hand or automatically to generate a combination of resistances, or change of pressures and thus change of flows, ensuring that in addition to the ultrafiltrate the exact amount of substitution liquid injected into the patient is removed from the patient before the end of a treatment session.
- a volumetric device 88 preferentially an ultrafiltration pump, can be used to create a depression.
- the dialysate supply line 84 that is connected between the pouches in the dialysate container 50 and the dialyzer 30 has a resistance that is sufficiently large that the depression created draws fluid more easily through the dialyzer membrane than from the dialysate pouches, so that the dialysate flows from the pouches 52 toward the dialyzer 30 remains substantially unchanged.
- the pressure in the container 50 must be sufficient so that the flow of the dialysate is between 80 and 500 milliliters per minute and preferably between 150 and 300 milliliters per minute in the dialysate feed line 84.
- the lid of the pressurized container remains closed while an outer cover of the machine is raised during use and standby pouches 62 are suspended vertically.
- the electronic controls are also arranged inside this housing. These are coupled to the control panel as illustrated in Fig. 9.
- a bag of medicinal substance as for example an anticoagulant connected by an appropriated line (no represented) to the arterial line 16 or to the venous chamber 74, this line comprising an adjustable fifth resistance generating device to cause the desired flow.
- an appropriated line no represented
- this line comprising an adjustable fifth resistance generating device to cause the desired flow.
- the same pressure applied to the medicinal substance fluid bag in the container and the restraint of the fifth resistance generating device allow the dialysis system to determine the flow of the medicinal substance and to regulate its flow precisely.
- the methods and the machine according to the invention can adjust to various uses as for example acute dialysis or chronic dialysis already mentioned but also automatic peritoneal dialysis.
- results of this examination which are reported in Fig. 10, indicate that the ultrafiltrate rate can be smoothly brought down.
- the results also indicate that the actual dialysate in volume correlated with the calculated dialysate in.
- the results further indicate that the actual ultrafiltrate correlated with the calculated with the calculated ultrafiltrate.
- Exhibit 2 The method set forth in Exhibit 1 was repeated to evaluate the ability to smoothly bring up the ultrafiltrate using the method of the present invention. The results of this examination are reported in Fig. 11
- Exhibit 4 The method set forth in Exhibit 1 was repeated to evaluate the ability to produce large negative ultrafiltrate flows using the method of the present invention. The results of this study are reported in Fig. 13.
- results also indicate that the actual dialysate in volume correlated with the calculated dialysate in.
- results further indicate that the actual ultrafiltrate correlated with the calculated with the calculated ultrafiltrate.
- Exhibit 1 The method set forth in Exhibit 1 was repeated to evaluate the relationship between the ultrafiltrate flow rate and the pressure in the dialysate supply mechanism.
- results indicate that the actual and projected values for the dialysate in and the ultrafiltrate closely correlate with each other.
- the results also indicate this correlation can be produced by ' modifying the pressure in the dialysate supply mechanism.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- External Artificial Organs (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001237688A AU2001237688A1 (en) | 2000-02-28 | 2001-02-27 | Method and system for hemodialysis for use in a non-clinical environment |
EP01910105A EP1261386A2 (en) | 2000-02-28 | 2001-02-27 | Method and system for hemodialysis for use in a non-clinical environment |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18528400P | 2000-02-28 | 2000-02-28 | |
US60/185,284 | 2000-02-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001064262A2 true WO2001064262A2 (en) | 2001-09-07 |
WO2001064262A3 WO2001064262A3 (en) | 2002-02-07 |
Family
ID=22680357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2001/000442 WO2001064262A2 (en) | 2000-02-28 | 2001-02-27 | Method and system for hemodialysis for use in a non-clinical environment |
Country Status (4)
Country | Link |
---|---|
US (1) | US20020023879A1 (en) |
EP (1) | EP1261386A2 (en) |
AU (1) | AU2001237688A1 (en) |
WO (1) | WO2001064262A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011113572A1 (en) * | 2010-03-15 | 2011-09-22 | Fresenius Medical Care Deutschland Gmbh | System for carrying out a blood treatment |
US9511182B2 (en) | 2010-05-20 | 2016-12-06 | Fresenius Medical Care Deutschland Gmbh | Medical treatment arrangement |
EP3431117B1 (en) | 2017-07-20 | 2020-07-15 | B. Braun Avitum AG | Disposal container for spent dialysis fluid and extracorporeal blood purification installation with such a disposal container |
US12303625B2 (en) | 2017-07-20 | 2025-05-20 | B. Braun Avitum Ag | Method for extracorporeal blood purification and dialysate disposal |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03007068A (en) * | 2001-02-07 | 2003-11-18 | Nephros Inc | Method and apparatus for a hemodiafiltration delivery module. |
US6926239B1 (en) * | 2004-01-23 | 2005-08-09 | Dimaggio Edward J. | Mounting assembly for a waste discharge line of a medical treatment apparatus |
US20060127609A1 (en) * | 2004-12-14 | 2006-06-15 | Davies Max I | Fire retardant molded artificial stone |
AU2006331191B2 (en) * | 2005-12-29 | 2012-02-02 | Danish Medical Research Aps | Method and apparatus for home dialysis |
AU2006335288B2 (en) * | 2006-01-06 | 2011-11-24 | Renal Solutions, Inc. | Dialysis machine with transport mode |
US20070158268A1 (en) * | 2006-01-06 | 2007-07-12 | Decomo Peter | Dual purpose acute and home treatment dialysis machine |
ITBO20090592A1 (en) * | 2009-09-17 | 2011-03-18 | Medica S R L | HOME DIALYSIS MACHINE |
US8753515B2 (en) | 2009-12-05 | 2014-06-17 | Home Dialysis Plus, Ltd. | Dialysis system with ultrafiltration control |
US8501009B2 (en) | 2010-06-07 | 2013-08-06 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Fluid purification system |
FR2980712B1 (en) * | 2011-10-03 | 2013-10-04 | Physidia | DIALYSIS MACHINE COMPRISING MEANS FOR ULTRAFILTRATION AND RETROFILTRATION |
ES2640953T3 (en) | 2011-10-07 | 2017-11-07 | Outset Medical, Inc. | Purification of heat exchange fluid for a dialysis system |
US20150314055A1 (en) | 2014-04-29 | 2015-11-05 | Michael Edward HOGARD | Dialysis system and methods |
EP3352811B1 (en) * | 2015-09-25 | 2020-12-09 | Medtronic Inc. | Selective sorbent-based regeneration dialysis systems |
WO2018022169A1 (en) * | 2016-07-25 | 2018-02-01 | Medtronic, Inc. | Infusate holder |
WO2018035520A1 (en) | 2016-08-19 | 2018-02-22 | Outset Medical, Inc. | Peritoneal dialysis system and methods |
US12201762B2 (en) | 2018-08-23 | 2025-01-21 | Outset Medical, Inc. | Dialysis system and methods |
WO2020086540A1 (en) * | 2018-10-25 | 2020-04-30 | Diality Inc. | Dual reservoir hemodialysis system |
JP7145119B2 (en) | 2019-04-23 | 2022-09-30 | 健治 上原 | Hemodialysis machines and connecting devices for dialyzers |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3841863A1 (en) * | 1988-12-13 | 1990-06-21 | Braun Melsungen Ag | DEVICE FOR CONTINUOUS HAEMOFILTRATION AND HAEMODIAFILTRATION |
US5211849B1 (en) * | 1991-10-11 | 1997-05-27 | Childrens Hosp Medical Center | Hemofiltration system and method |
US5910252A (en) * | 1993-02-12 | 1999-06-08 | Cobe Laboratories, Inc. | Technique for extracorporeal treatment of blood |
-
2001
- 2001-02-27 WO PCT/IB2001/000442 patent/WO2001064262A2/en not_active Application Discontinuation
- 2001-02-27 EP EP01910105A patent/EP1261386A2/en not_active Ceased
- 2001-02-27 AU AU2001237688A patent/AU2001237688A1/en not_active Abandoned
- 2001-02-28 US US09/796,096 patent/US20020023879A1/en not_active Abandoned
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011113572A1 (en) * | 2010-03-15 | 2011-09-22 | Fresenius Medical Care Deutschland Gmbh | System for carrying out a blood treatment |
US9592329B2 (en) | 2010-03-15 | 2017-03-14 | Fresenius Medical Care Deutschland Gmbh | System for carrying out a blood treatment |
EA027694B1 (en) * | 2010-03-15 | 2017-08-31 | Фрезениус Медикел Кэар Дойчланд Гмбх | System for carrying out a blood treatment |
KR101859780B1 (en) | 2010-03-15 | 2018-05-18 | 프레제니우스 메디칼 케어 도이치란드 게엠베하 | System for carrying out a blood treatment |
US9511182B2 (en) | 2010-05-20 | 2016-12-06 | Fresenius Medical Care Deutschland Gmbh | Medical treatment arrangement |
EP3431117B1 (en) | 2017-07-20 | 2020-07-15 | B. Braun Avitum AG | Disposal container for spent dialysis fluid and extracorporeal blood purification installation with such a disposal container |
US12303625B2 (en) | 2017-07-20 | 2025-05-20 | B. Braun Avitum Ag | Method for extracorporeal blood purification and dialysate disposal |
Also Published As
Publication number | Publication date |
---|---|
EP1261386A2 (en) | 2002-12-04 |
AU2001237688A1 (en) | 2001-09-12 |
US20020023879A1 (en) | 2002-02-28 |
WO2001064262A3 (en) | 2002-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020023879A1 (en) | Method and system for hemodialysis for use in a non-clinical environment | |
AU754841B2 (en) | Dialysis machine, in particular for home use | |
JP6936267B2 (en) | High convection home hemodialysis / hemofiltration and adsorbent system | |
US6916424B2 (en) | Method and apparatus for a hemodiafiltration delivery module | |
EP0969887B1 (en) | Hemofiltration system | |
EP2029192B1 (en) | Dynamic weight balancing of flow in kidney failure treatment systems | |
EP0607301B1 (en) | Hemofiltration system | |
JPS63122462A (en) | Treatment apparatus for extracorporeal circulation blood | |
JP2002000012U (en) | System for performing continuous peritoneal dialysis | |
DK172894B1 (en) | hemodialysis | |
JPWO2008120803A1 (en) | Continuous blood purification device with syringe pump | |
US20230201432A1 (en) | Determining a Volume of a Container for Dialysis Treatment | |
US20230414852A1 (en) | Peritoneal dialysis system having disinfection gas relief | |
CN118159314A (en) | Peritoneal dialysis system with carbon dioxide infusion to inhibit the production of and/or remove calcium carbonate | |
CN116457038A (en) | Medical fluid generating system | |
CN116348159A (en) | Medical fluid generating system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001910105 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001910105 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWR | Wipo information: refused in national office |
Ref document number: 2001910105 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001910105 Country of ref document: EP |